Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07086755 · ClinicalTrials.gov registry record · Phase 2
Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury
A Phase 2 study of Nonintubated Acute Respiratory Distress Syndrome (ARDS) and Pathogen-associated Lung Injury, sponsored by Bentley J. Bobrow.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 1,100
- Enrollment target
- 1
- Study location
NCT07086755 is a Phase 2 study of Nonintubated Acute Respiratory Distress Syndrome (ARDS) and Pathogen-associated Lung Injury that is actively recruiting participants, run by Bentley J. Bobrow. The registered enrollment target is 1,100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07086755, a Phase 2 study of Nonintubated Acute Respiratory Distress Syndrome (ARDS) and Pathogen-associated Lung Injury, is actively recruiting participants, sponsored by Bentley J. Bobrow.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the efficacy and safety of vadadustat for treating hospitalized patients with nonintubated Acute Respiratory Distress Syndrome (ARDS) secondary to pathogen-associated lung injury.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Vadadustat 900mg
- DRUG Vadadustat 1200mg
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2025-10-23 |
| Est. Completion | 2026-07-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07086755
The ClinicalTrials.gov registry entry for NCT07086755 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bentley J. Bobrow, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nonintubated Acute Respiratory Distress Syndrome (ARDS) appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT07086755 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07086755 about?
NCT07086755 is a clinical study titled "Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury". The objective of this study is to assess the efficacy and safety of vadadustat for treating hospitalized patients with nonintubated Acute Respiratory Distress Syndrome (ARDS) secondary to pathogen-associated lung injury.
What is the current status of trial NCT07086755?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 1,100 participants. The study started on 2025-10-23. Estimated completion is 2026-07-01.
What conditions does trial NCT07086755 study?
This clinical trial studies the following conditions: Nonintubated Acute Respiratory Distress Syndrome (ARDS), Pathogen-associated Lung Injury.
What interventions are being tested in trial NCT07086755?
The interventions under investigation include: Placebo (DRUG), Vadadustat 900mg (DRUG), Vadadustat 1200mg (DRUG).
Who is sponsoring clinical trial NCT07086755?
This trial is sponsored by Bentley J. Bobrow, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07086755 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Nonintubated Acute Respiratory Distress Syndrome (ARDS)
All registered trials for this condition
Pathogen-associated Lung Injury
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.